Company Valuation: COSMOS Pharmaceutical Corporation

Data adjusted to current consolidation scope
Fiscal Period: May 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 483,107 525,081 502,890 700,001 476,495 510,099 - -
Change - 8.69% -4.23% 39.2% -31.93% 7.05% - -
Enterprise Value (EV) 1 450,132 497,354 477,918 692,920 476,495 538,524 547,718 553,399
Change - 10.49% -3.91% 44.99% -31.23% 13.02% 1.71% 1.04%
P/E 20.9x 22.1x 20.6x 22.6x 14.9x 15.9x 15x 14x
PBR 2.54x 2.49x 2.17x 2.72x 1.68x 1.65x 1.52x 1.4x
PEG - 7.98x 7.61x 0.8x 4.32x 104.44x 2.39x 2.1x
Capitalization / Revenue 0.64x 0.63x 0.52x 0.69x 0.43x 0.43x 0.4x 0.37x
EV / Revenue 0.6x 0.6x 0.5x 0.69x 0.43x 0.46x 0.43x 0.4x
EV / EBITDA 10x 10.5x 9.29x 11.1x 7.12x 7.63x 7.24x 6.83x
EV / EBIT 15.1x 16.5x 15.2x 17.1x 11.3x 12.2x 11.6x 11x
EV / FCF -39.1x 93.5x -222x -807x -20.6x -68.2x -189x -874x
FCF Yield -2.56% 1.07% -0.45% -0.12% -4.85% -1.47% -0.53% -0.11%
Dividend per Share 2 40 50 60 70 82 85.3 90.01 94.2
Rate of return 0.66% 0.75% 0.95% 0.79% 1.36% 1.33% 1.4% 1.46%
EPS 2 292.4 300.5 308.6 390.9 404.3 404.9 430.3 459
Distribution rate 13.7% 16.6% 19.4% 17.9% 20.3% 21.1% 20.9% 20.5%
Net sales 1 755,414 827,697 964,989 1,011,390 1,099,583 1,182,344 1,271,788 1,369,821
EBITDA 1 44,906 47,496 51,425 62,633 66,929 70,584 75,645 81,080
EBIT 1 29,796 30,128 31,501 40,404 42,353 44,273 47,144 50,404
Net income 1 23,155 23,797 24,454 30,978 32,046 32,103 34,113 36,374
Net Debt 1 -32,975 -27,727 -24,972 -7,081 - 28,425 37,619 43,300
Reference price 2 6,100.00 6,630.00 6,345.00 8,832.00 6,012.00 6,436.00 6,436.00 6,436.00
Nbr of stocks (in thousands) 79,198 79,198 79,258 79,257 79,257 79,257 - -
Announcement Date 7/11/22 A 7/10/23 A 7/12/24 A 7/11/25 A 7/13/26 A - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
15.89x0.46x7.63x1.33% 3.25B
21.18x0.35x5.59x2.26% 6.24B
13.98x0.35x5.19x1.53% 2.85B
12.75x0.42x5.29x3.8% 2.7B
19.99x0.77x10.67x1.58% 2.42B
14.21x0.43x4.15x3.93% 1.43B
25.06x0.44x6.05x3.12% 308M
Average 17.58x 0.46x 6.37x 2.51% 2.74B
Weighted average by Cap. 17.42x 0.44x 6.38x 2.26%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 3349 Stock
  4. Valuation COSMOS Pharmaceutical Corporation
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!